# Clustering Approach 3 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.00610065783508973	Range of duration = 0.03 to 187.07, nDeath = 30, nCensor = 279
2	AGE	ANOVA	0.0168629171848442	Range of values = 31 to 90, Mean = 63.4872, StdDev = 11.1188, nMissing = 1
3	HISTOLOGICAL.TYPE	Chi-square test	1.04708246561412e-15	nTypes = 6 (ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1)/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2)/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3)/MIXED SEROUS AND ENDOMETRIOID/SEROUS ENDOMETRIAL ADENOCARCINOMA), nPatients = 229/6/1/3/16/58
4	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.0389542928267065	nTypes = 2 (NO/YES), nPatients = 79/234
5	NEOADJUVANT.THERAPY	Fisher's exact test	0.00453586762873404	nTypes = 2 (NO/YES), nPatients = 243/70